GovChime
Notice ID: 0b1e9e775a7b42578687efcf102f0e6aCombined Synopsis/Solicitation

DNA SERVICES: ANTIBODY GENE SYNTHESIS, SUBCLONING AND PLASMID PREPARATION

Archived on August 24, 2024. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
4:00 PM UTC−04:00
Posted
July 31, 2024
Notice type
Combined Synopsis/Solicitation
NAICS
541990: All Other Professional, Scientific, and Technical Services
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
Bethesda, MD, 20814
Last updated
Dec 4, 2025

Identifiers

Solicitation number
NOI-NIAID-24-2228446
Notice ID
0b1e9e775a7b42578687efcf102f0e6a

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Gene Universal, 200 Continental Dr. Ste 401, Newark, DE19713. The mission of the NIH Vaccine Research Center (VRC) is to facilitate the development of vaccines against HIV-AIDS. Our goal is to develop immunogens that will elicit broadly neutralizing antibodies and will be used in vaccine design. One of the aims of the project is to obtain atomic level structures of the envelope glycoproteins that are the sole exterior target for neutralizing antibodies. Another aim is to develop neutralizing antibodies against HIV. Vaccine immunogens are custom designed at VRC and thus is not commercially available. The DNA plasmids for the designed vaccine immunogens and antibodies will be synthesized by a service provider in order to be expressed and purified at VRC for further characterization. This is a follow-on requirement for the VRC, Vaccine Research Center. Study title is, Generative AI-guided design of HIV-1 cocktail immunogens; study # NAI24007001. Changing provider now will compromise the integrity of our data. We have been using Gene Universal for DNA synthesis services for this ongoing project, and it has proven to support our protocols in the development of vaccines for HIV and other viruses. No substitutions will be acceptable for these services for this follow-on project NAI24007001 The statutory authority for this sole source requirement is 41 U.S.C.1901 (e) (2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line shall be referenced, NOI-NIAID-24-2228446) to Diana Rohlman at diana.rohlman@nih.gov by August 9, 2024 4:00 pm EST. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:NOI-NIAID-24-2228446
  1. Combined Synopsis
  1. Combined SynopsisCurrentJul 31, 2024

    DNA SERVICES: ANTIBODY GENE SYNTHESIS, SUBCLONING AND PLASMID PREPARATION

    Notice 0b1e9e775a7b42578687efcf102f0e6a on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NOI-NIAID-24-2228446

Archive Date

Aug 24, 2024

Office Address

BETHESDA, MD, 20892